Cresco Labs Inc. (CRLBF) stock
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Cresco Labs total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cresco Labs's total debt was $431.18M at Dec 31, 2025. For fiscal 2025 it was $431.18M, down 9.3% from the year before. The highest annual figure on record is $509.53M in fiscal 2023.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $431.18M | -9.3% |
| FY2024 | Dec 31, 2024 | $475.29M | -6.7% |
| FY2023 | Dec 31, 2023 | $509.53M | +4.4% |
| FY2022 | Dec 31, 2022 | $487.87M | +0.6% |
| FY2021 | Dec 31, 2021 | $485.01M | +72.4% |
| FY2020 | Dec 31, 2020 | $281.36M | +51056.9% |
| FY2019 | Dec 31, 2019 | $550.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $431.18M | -11.1% |
| Q4 FY2024 | Dec 31, 2024 | $475.29M | +68.9% |
| Q4 FY2023 | Dec 31, 2023 | $509.53M | +92541.8% |
| Q4 FY2022 | Dec 31, 2022 | $487.87M | – |
| Q4 FY2021 | Dec 31, 2021 | $485.01M | – |
| Q4 FY2020 | Dec 31, 2020 | $281.36M | – |
| Q4 FY2019 | Dec 31, 2019 | $550.00K | – |
See a number that looks wrong?